OTTI SLAMS JULIUS ABURE OVER CONTINUED SALE OF LABOUR PARTY NOMINATION FORMS. (PHOTO).

Image
 Otti Slams Julius Abure Over Continued Sale of Labour Party Nomination Forms Abia State Governor, Dr. Alex Otti, has strongly criticised the former National Chairman of the Labour Party (LP), Julius Abure, for proceeding with the sale of governorship nomination forms despite opposition from the Independent National Electoral Commission (INEC) and subsisting court rulings. The criticism follows a viral photograph showing Abure presenting a Labour Party nomination form to a former National Vice Chairman of the party, Ceekay Igara, in the company of other party members. Reacting through his Chief Press Secretary, Mr. Ukoha Ukoha, Governor Otti questioned Abure’s continued claim to leadership of the party.  Ukoha insisted that both judicial pronouncements and INEC’s position have effectively sidelined Abure, describing his actions as being in contempt of court. “I think Abure is in a better position to explain the grounds on which he is still parading himself after a Federal High...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).